Rockweed

Other Names

Algue noueuseAn fheamainn bhuíAscoAscophylle noueuseAscophyllum laevigataAscophyllum nodosumAtlantic kelpBlack tangBladder fucusBladder wrackBladderwrackBlasentangBottle kelpCut weedCutweedDyer's FucusDyers fucusEgg wrackFeamainn bhuíFucusFucus distichusFucus gardneriFucus nodosusFucus spiralisFucus vésiculeuxFucus vesiculosusFucus vesiculosus var. spiralisGoémon noirKelpKelp-wareKelpwareKnobbed wrackKnotentangKnotswierKnotted kelpKnotted wrackMarine oakNorwegian kelpOcean kelpPacific rockweedPaddy tangPopping wrackQuercus marinaRed fucusRock weedRock wrackRockwrackSea grapesSea kelpSea oakSea whistleSea whistlesSea wrackSeawrackSwine tangVarechVarech vésiculeuxYellow tang

Synopsis

Rockweed: A Comprehensive Encyclopedic Reference

1. Identity and Botanical Classification

The common name rockweed is applied to several related species of brown macroalgae found on rocky intertidal shores of the North Atlantic, and occasionally on Pacific coasts. In its broadest usage, the term "rockweed" may refer to Ascophyllum nodosum (also called knotted wrack or Norwegian kelp), Fucus gardneri, and Fucus vesiculosus (also called bladderwrack), as well as Silvetia, a brown seaweed of Pacific Ocean rocky seashores. In dietary supplement and nutraceutical contexts, the term most commonly refers specifically to Ascophyllum nodosum and, to a significant extent, Fucus vesiculosus, which are often studied and formulated together.

1.1 Ascophyllum nodosum

Ascophyllum nodosum, commonly known as rockweed, is a brown alga belonging to the family Fucaceae of the order Fucales (class Phaeophyceae, phylum Ochrophyta). Its common names include knotted wrack, egg wrack, feamainn bhuí, rockweed, knotted kelp, and Norwegian kelp. It grows only in the northern Atlantic Ocean, along the north-western coast of Europe (from the White Sea to Portugal) including east Greenland and the north-eastern coast of North America. It is a common fucoid alga found on sheltered, intertidal, and rocky shores; the genus is monotypic and basal in Fucaceae and is found from Arctic Canada, Greenland, Iceland, and northern Norway to the southern reaches of Portugal and Long Island, USA.

Morphologically, the entire plant can reach up to 6 meters in length in deeper water but is more often 30 to 150 cm, and it tends to grow in thick, tangled beds that completely cover rocks with a mat at low tide. A. nodosum has single air bladders and the fronds lack a midrib, distinguishing it from F. vesiculosus, whose bladders are generally in pairs along either side of a midrib.

1.2 Fucus vesiculosus (Bladderwrack)

Fucus vesiculosus, commonly known as bladderwrack or rockweed, is a large, perennial brown alga in the family Fucaceae, characterized by its flat, dichotomously branched fronds that can reach up to 2 meters in length and feature prominent midribs along with paired, gas-filled bladders that provide buoyancy. Common names for Fucus vesiculosus vary by region and include bladderwrack, rockweed, black tang, bladder fucus, sea oak, cut weed, dyers fucus, and red fucus. Both Fucus vesiculosus and Ascophyllum nodosum, belonging to the same order Fucales, are popular sources of commercial fucoidans.

1.3 Common Forms and Preparations

Rockweed species are commercially harvested and processed into a variety of forms for nutraceutical and functional food applications. These include dried whole thallus powder, capsules or tablets containing dried or standardized extracts, liquid extracts prepared with various solvents (water, ethanol, or alkaline solutions), and functional food ingredients (incorporated into bread or other food matrices). The British Herbal Pharmacopoeia historically specified preparations including dried thallus at a dose of 5–10 g, or liquid extract in 25% ethanol at 4–8 ml. Soft extracts prepared with ethanol (45%) at 200–600 mg and liquid extracts prepared with ethanol (45%) at 4–8 ml were also described. In modern supplement markets, the harvested biomass is a valuable resource for agriculture, cosmetics, and human nutrition.

2. Traditional and Historical Use

2.1 European and North Atlantic Coastal Traditions

Rockweed has been used as a convenient crop fertilizer or animal feed supplement for centuries. Cast-ashore rockweed was piled into horse-drawn wagons and then spread onto fields in the fall, where it slowly released nitrogen and minerals such as magnesium into the soil over the winter; in spring it was tilled into the soil as organic matter. Many coastal communities still have "ware roads" once used to transport "seaware" and other goods from the shore to fields and villages.

Fucus species have been used in traditional medicine for centuries, particularly in European and Asian cultures, and Fucus vesiculosus is well-known for its high iodine content, which has made it a historical remedy for thyroid disorders such as goiter. Historically, it was also used as a source of iodine to prevent goiter, a condition caused by iodine deficiency.

The British Herbal Pharmacopoeia (1983) contains a monograph on Fucus (bladderwrack), describing the herbal substance as containing small variable amounts of iodine with an upper limit of 0.2%, and mentioning the following therapeutic indications: myxedema, lymphadenoid goiter, obesity, rheumatism, and rheumatoid arthritis.

In traditional medicine, rockweed has been used for various purposes including treating skin conditions, arthritis, and digestive issues; in some coastal communities it was applied topically as a poultice to soothe inflammation and promote wound healing.

2.2 Indigenous North American Traditions

Among Indigenous peoples of the North Pacific coast, rockweed species (known by names including Caritet in Kodiak Alutiiq, Tayeidí in Lingít, and Elquat epuit in Yup'ik) could be eaten raw, stir-fried, or cooked with clams and mussels to boost flavor, with the inner gel acting as a thickening agent for soups and stews. For over 10,000 years, traditional food has connected Indigenous peoples with the land and sea through cultural rights and traditional practices passed down through generations.

2.3 Asian Traditions

Historically, Asian civilizations used seaweeds for various medicinal purposes by boiling the seaweed in water and using the decoction as a drug; Japanese and Chinese practitioners have been recorded using seaweeds in herbal medicines as far back as 300 BC. The range of ailments reported to have been treated with seaweed or seaweed-derived products is varied, and includes treatments for cancer, digestive problems, dropsy, eczema, glandular problems, goitre, gout, hyperthyroidism, parasitic infection, and renal disorders.

2.4 Agricultural Use

Beyond human medicine, rockweed has historically been used for fertilizers and as animal feed due to its high mineral content. In traditional agricultural practices, rockweed has been used as a soil amendment and fertilizer, providing essential nutrients and improving soil structure.

3. Key Constituents and Active Compounds

Rockweed, particularly Ascophyllum nodosum, contains a complex array of bioactive compounds across several chemical classes.

3.1 Polysaccharides

A. nodosum is a rich source of various bioactive phenolic compounds such as phlorotannins and unique polysaccharides, including alginic acid (28%), fucoidans (11.6%), mannitol (7.5%), and laminarin (4.5%). A separate analysis found slightly different ranges: A. nodosum is rich in diverse bioactive phenolic compounds such as phlorotannins, and unique polysaccharides, including alginic acid (15–30%), fucoidans (4–10%), mannitol (5–10%), and laminarin (0–10%).

Fucoidans (sulfated polysaccharides): The bioactive biopolymers of A. nodosum include alginates, fucoidan, and laminarin; the plant contains sulfated polysaccharide chains known as fucoidans, which have alternate (1–3) and (1–4) linkages with both disulfate and trisulfate sugars. Ascophyllan (xylofucoglycuronan) is a fucose-containing sulfated polysaccharide unique to A. nodosum with similar but distinct composition from fucoidans; specifically, ascophyllan has fucose and xylose in about equimolecular proportion, whereas fucoidans have a much higher ratio of fucose than xylose.
Alginates: Alginates, composed of mannuronic and guluronic acids, influence water retention and viscosity, making them valuable in food stabilization and biomedical applications.
Laminarin: Laminarin, a β-1,3-glucan, serves as an energy reserve while demonstrating biofunctional properties.

3.2 Phlorotannins

Brown algae of the Phaeophyceae family reveal high levels of phlorotannins — a type of polyphenol unique to aquatic organisms — which are oligomers and polymers of phloroglucinol (1,3,5-trihydroxybenzene) linked by the acetate pathway. Phlorotannins, polyphenols unique to brown algae, contribute to its defense against herbivory and oxidative stress and are synthesized via the acetate-malonate pathway, ranging from simple monomers to highly polymerized forms. Notable phlorotannin compounds detected in rockweed include 2-phloroeckol, 6,6′-bieckol, 7-phloroeckol, eckol, fucophlorethols, fucodiphloroethol G, phlorofucofuroeckol A and B, tetraphlorethols, and triphlorethols.

3.3 Other Phytochemicals and Nutritional Compounds

It is also a nutritionally rich source of protein (5–10%), lipids (2–7%), carbohydrates (40–70%), and ash (15–25%). A. nodosum contains different carotenoids including fucoxanthin, fucoxanthinol, zeaxanthin, violaxanthin, α- and β-carotene, and others; chlorophyll; anthocyanin; simple phenolics like catechin and epigallocatechin; hydroxybenzoic acid; coumaric acid; cinnamic acid; rosmarinic acid; and caffeic acid; as well as amino acids. Rockweed is also a notable natural source of iodine, as well as minerals including calcium, magnesium, and potassium.

3.4 Seasonal and Geographic Variation in Constituents

The total content of dominating carbohydrates (fucoidan, mannitol, alginate, and laminarin) ranged from 347 mg/g DW to 528 mg/g DW depending on geographic origin; the proportion of two main structural monosaccharides of fucoidan (fucose and xylose) differed significantly between seas and reproductive phase. Some of these compounds exhibit significant seasonal variation.

4. Mechanisms of Action

4.1 Enzyme Inhibition (Carbohydrate Digestion)

The inhibitory capacities of polyphenols — specifically phlorotannins from Ascophyllum nodosum — against digestive enzymes such as α-amylase and α-glucosidase have been explored, and results suggest these polyphenols hold significant potential as enzyme inhibitors, though inhibitory activity may vary depending on extraction conditions and the specific enzyme involved. Preclinical and clinical studies have demonstrated that algal extracts can reduce glucose release from maltose and/or sucrose by inhibiting α-glucosidase, an enzyme located in the brush-border membrane of the small intestine; α-glucosidase inhibitors such as acarbose and voglibose are widely used in the treatment of type 2 diabetes. Phlorotannins from A. nodosum reduce serum glucose and insulin levels by decreasing the activities of carbohydrate-digestion enzymes including α-amylase and α-glucosidase.

4.2 Modulation of Glucose Transport and AMPK Signaling

Fucoidan found in A. nodosum also has glucose-lowering potential by reducing carbohydrate enzyme activity and modulating the glucose-related transporter GLUT-4 and AMP-activated protein kinase (AMPK) activity.

4.3 Lipid Metabolism: Pancreatic Lipase and Intestinal Absorption

Alginates have been shown to inhibit the digestive enzymes pancreatic lipase and pepsin and diminish the intestinal absorption of triacylglycerols, cholesterol, and glucose; as with other dietary fibres, consumption of alginates could delay gastric emptying, increase digestive fluid viscosity, and reduce calorie intake through enhanced satiety.

4.4 Antioxidant Activity

Phlorotannin extracts from F. vesiculosus showed good radical-scavenging activity, particularly towards nitric oxide (NO•); subsequent subfractions showed inhibition of lipopolysaccharide-induced NO• production in macrophages, with stronger effects observed for fractions of lower molecular weights.

4.5 Anti-Inflammatory Mechanisms

Of three intracellular inflammatory markers analyzed, inducible NO• synthase showed the highest sensitivity to phlorotannin-rich samples, followed by interleukin-1β and cyclooxygenase-2. Research has shown that fucoidans from A. nodosum can inhibit inflammation via blocking of TLR/NF-κB signaling pathways.

4.6 Thyroid Mechanism (Iodine-Mediated)

Fucus vesiculosus is used as a natural source of iodine; the iodine content gives some plausibility to a possible stimulating effect on the thyroid gland. Fucus has a high halide mineral content, including iodine with good bioavailability, and selenium, which is of central importance in the regulation of the thyroid gland; the presence of iodine and specific selenoproteins implicated in thyroid hormone metabolism within the colloid of the thyroid gland may stimulate the gland to produce thyroxine.

4.7 Anti-Fibrotic and Connective Tissue Effects

Fucus inhibits collagenase and elastase, enzymes that metabolically break down collagen and elastin, which may explain the plant's traditional use in cosmetic facials and body wraps; this action may help protect thyroid cells from inflammatory damage. Seaweed-derived fucoidans have been extensively studied for their anti-inflammatory, anticoagulant, antiangiogenic, and antioxidant properties; in ex vivo experiments, fucoidans have been shown to protect elastic fibers from proteolytic enzymes, suggesting a possible use in the therapy of joint inflammation.

4.8 Gut Microbiota Modulation

Using an in vitro colonic fermentation model, gut microbiota could utilize a proportion of A. nodosum polysaccharide (ANP) to increase the concentrations of short-chain fatty acids (SCFAs) and decrease ammonia content, which may help protect against colonic inflammation.

5. Scientific Evidence by Area of Use

5.1 Glycemic Control and Type 2 Diabetes Risk

5.1.1 In Vitro and Preclinical Evidence

Studies conducted in vitro and in diabetic mice show that Ascophyllum nodosum (Rockweed) and Undaria pinnatifida (Wakame) regulate plasma glucose. In normal-diet mice, the phytocomplex from Fucus vesiculosus and Ascophyllum nodosum only delayed and reduced the peak of blood glucose without changing the area under the blood glucose curve; in a model of non-alcoholic steatohepatitis (NASH), the phytocomplex was able to reduce both the postprandial glycaemic peak and the AUC.

5.1.2 Human Clinical Evidence

A study examining the impact of brown seaweed on post-load plasma glucose and insulin concentrations enrolled twenty-three participants (11 men, 12 women) aged 19–59 years in a double-blind, randomized crossover design; the single ingestion of 500 mg of brown seaweed had no significant effect on the glucose response. However, these data suggest that brown seaweed may alter insulin homeostasis in response to carbohydrate ingestion.

The effects of an extract of the brown seaweed Ascophyllum nodosum on postprandial glucose and insulin responses to white bread were investigated in an acute, randomized, double-blind, three-arm, crossover, controlled trial in healthy, normoglycemic subjects; sixteen subjects were administered either control white bread (50 g total digestible carbohydrates) or white bread with 500 mg or 1000 mg of the extract; significant inter-individual variation in the glycaemic response to white bread was observed; analysis of the responses of all subjects to either dose versus control revealed no significant effects of treatment.

A 12-week parallel, double-blind, randomized controlled trial enrolled fifty-six overweight/obese, dysglycemic, and insulin-resistant men and women; subjects were administered 500 mg/d of brown seaweed extract (Ascophyllum nodosum and Fucus vesiculosus) or placebo combined with individualized nutritional advice for moderate weight loss; glycemic, anthropometric, blood pressure, heart rate, body composition, lipid profile, gut integrity, and oxidative and inflammatory markers were measured; no effect was observed on blood glucose.

An addendum EMA assessment report found that among clinical studies demonstrating beneficial potential of brown seaweeds in the area of metabolic syndrome, all studies showing positive results were conducted with a combination of two species: Ascophyllum nodosum and Fucus vesiculosus.

Only two of the identified human studies have been conducted in patients with type 2 diabetes mellitus, and they have limited evidence. A meta-analysis suggests that brown seaweed has a significant effect on glucose control overall, though this encompasses multiple species and study designs.

Evidence strength: Human clinical evidence for glycemic benefit of rockweed is weak to preliminary. Results across studies are mixed, sample sizes are small, and the most positive findings come from uncontrolled or observational studies or from combinations with other agents (e.g., chromium picolinate). Mechanistic plausibility exists in vitro and in animal models.

5.2 Metabolic Syndrome and Cardiovascular Risk Factors

A nutraceutical product (Gdue) containing a combination of Ascophyllum nodosum and Fucus vesiculosus in addition to chromium picolinate was studied for potential usefulness in the treatment of dysglycemia, overweight, and other components of the metabolic syndrome. A longitudinal, retrospective, observational study was conducted among primary care physicians; the impact of 180 days of administration was assessed on body weight, waist circumference, fasting blood glucose, HbA1c, lipid profile, and blood pressure levels. Overall, 505 patients were enrolled; after 6 months of treatment, body weight was reduced on average by 7.3 kg, waist circumference by 7.5 cm, fasting blood glucose by 16.3 mg/dL, HbA1c by 0.55%, systolic and diastolic blood pressure by 7.1 and 4.2 mmHg respectively, LDL cholesterol by 18.2 mg/dL, and triglycerides by 39 mg/dL; HDL cholesterol was significantly increased by 2.9 mg/dL; and the 10-year risk of cardiovascular events significantly decreased by 1.8%, corresponding to a relative risk reduction of 27.7%.

The presence of chromium picolinate, known as a hypoglycemic agent, could have accentuated the impact of the seaweed extract on glycemic response; in the positive studies, the effects were more pronounced after 6 months than after 3 months, with additional reduction of fasting plasma glucose, glycated hemoglobin, and insulin resistance.

Evidence strength: The most dramatic improvements in metabolic syndrome parameters come from observational (non-randomized) studies using combination products that include chromium picolinate alongside the seaweed extract, confounding attribution to rockweed specifically. The evidence base relies mainly on cell line and small animal models, with few studies to date involving humans. Larger, well-controlled randomized clinical trials isolating the effect of rockweed alone are needed.

5.3 Thyroid Function and Iodine Status

A pilot study conducted in women with iodine insufficiency showed that taking Ascophyllum nodosum capsules at a dose of 500 mg per day for 14 days nearly tripled urinary iodine excretion and increased thyroid-stimulating hormone levels by 36% compared with baseline. Bladderwrack contains variable levels of iodine, and as a result has been used to treat thyroid disorders such as goiters; while evidence does suggest thyroid activity, there is not enough research to support this use of bladderwrack formally.

Evidence strength: The iodine-mediated effect on thyroid physiology is mechanistically well-grounded, but controlled clinical trials of rockweed specifically for thyroid conditions are lacking. The EMA has not granted well-established use status for this indication; use is classified as traditional.

5.4 Antioxidant and DNA Protection

Of the three groups of seaweeds, brown seaweeds contain more bioactive components than either red or green seaweeds; among different brown seaweed species, Ascophyllum nodosum and Fucus vesiculosus have the highest antioxidant values and highest total phenolic content. Among different brown seaweed species, Ascophyllum nodosum and Fucus vesiculosus have the highest antioxidant values and highest total phenolic content. A randomized controlled trial examined the impact of a polyphenol-rich extract from A. nodosum on DNA damage and antioxidant activity in an overweight or obese population, though detailed results require examination of the primary source.

Evidence strength: Antioxidant capacity of rockweed extracts is well established in vitro. Human clinical evidence for meaningful antioxidant protection in vivo is very limited.

5.5 Anti-Inflammatory Effects

Among the various bioactive constituents, there is some evidence that components in seaweed may have beneficial effects including anticoagulant, anti-inflammatory, antioxidant, anticarcinogenic, and antiviral activities. However, the evidence base relies heavily on cell line and small animal models, with few studies to date involving humans. In a rat model study, treatment with F. vesiculosus extract significantly reduced oxidative stress and inflammation caused by intestinal ischemia-reperfusion injury, restoring measured parameters (MDA, SOD, CAT, IL-10) to levels comparable to the sham group, and histological examination confirmed preservation of intestinal mucosal integrity.

Evidence strength: Preclinical only at present. No controlled human trials specifically examining anti-inflammatory endpoints for rockweed as a sole intervention have been identified.

5.6 Body Weight and Appetite

People use Fucus vesiculosus for thyroid disorders, obesity, aging skin, constipation, and many other conditions, but there is no good scientific evidence to support these uses. Bladderwrack and other seaweed products are often marketed for weight-loss; however, safety and effectiveness have not been studied in humans. In animal models, A. nodosum has been investigated for anti-obesity properties through inhibition of adipose tissue accumulation, and an A. nodosum-enriched bread product was studied in overweight males for effects on subsequent energy intake.

Evidence strength: Very weak. Human evidence for body weight benefit from rockweed as a standalone ingredient is currently insufficient.

5.7 Gut Health and Prebiotic Potential

The antibacterial and prebiotic potential of Ascophyllum nodosum was investigated because this seaweed species has a high polysaccharide content, characterized by monthly fluctuation ranging from approximately 50% in February to approximately 70% in November. Using an in vitro colonic fermentation model, results indicate that gut microbiota could utilize a proportion of A. nodosum polysaccharide to increase concentrations of short-chain fatty acids (SCFAs) and decrease ammonia content, suggesting a mechanism underlying the anti-inflammatory effect.

Evidence strength: Prebiotic research on rockweed is primarily in vitro or conducted in animal models. Human trials investigating gut microbiota modulation by rockweed are not yet available.

5.8 Anticoagulant and Cardiovascular Effects

Seaweed-derived fucoidans have been extensively studied for their anti-inflammatory, anticoagulant, antiangiogenic, and antioxidant properties. Fucus vesiculosus might slow blood clotting. These anticoagulant effects, attributed to the structural similarity of fucoidans to heparin, are primarily documented in vitro and in animal experiments. No dedicated human clinical trials have investigated anticoagulant endpoints for rockweed supplementation.

Evidence strength: In vitro and preclinical only. The anticoagulant properties are mechanistically plausible but not substantiated by human trials.

5.9 Anticancer Properties

Several brown algae including bladderwrack (Fucus vesiculosus) appear to suppress the growth of various cancer cells in animal and laboratory studies; however, there is currently a lack of reliable human studies available to support a recommendation for use in cancer. Fucoidan, a sulfated polysaccharide found in Fucus, has demonstrated anticancer activities in vivo through the modulation of host immune systems and inhibition of tumor angiogenesis.

Evidence strength: Preclinical only. Anticancer evidence is confined to cell lines and animal models. No human trials exist.

5.10 Antiviral Activity

A 2024 study published in Viruses investigated phlorotannin-rich Ascophyllum nodosum seaweed extract in the context of influenza infection. There is some evidence that seaweed components may have antiviral activities, though clinical substantiation in humans is absent.

Evidence strength: Preliminary and preclinical. Clinical human antiviral trials have not been conducted with rockweed preparations.

6. Body Systems Associated with Rockweed

Endocrine system (thyroid): Iodine content plausibly supports thyroid hormone synthesis; historically the most documented traditional use.
Metabolic / glycemic system: Phlorotannins and fucoidans inhibit carbohydrate-digesting enzymes and modulate GLUT-4 and AMPK signaling in preclinical models.
Cardiovascular system: Alginate-mediated reduction in lipid absorption; fucoidan's anticoagulant properties; mixed evidence from combination supplement studies on lipid profiles and blood pressure.
Gastrointestinal system: Alginates and polysaccharides increase viscosity, delay gastric emptying, may support satiety; prebiotic potential demonstrated in vitro and animal models.
Immune system: Fucoidans and ascophyllan have demonstrated immunomodulatory effects in cell and animal studies, including induction of Th1/Tc1 immune responses.
Integumentary system (skin): Traditional topical use for wound healing and inflammation; inhibition of collagenase and elastase may underlie cosmetic applications.
Musculoskeletal system: Traditional use for arthritis and rheumatism; fucoidan's protection of elastic fibers and potential anti-inflammatory effects on joints are preclinical.

7. Dosage Forms and Doses Reported in Studies

The following dosages are drawn specifically from the sources identified above and should not be taken as clinical recommendations:

A randomized crossover trial used a single dose of 500 mg of brown seaweed (combination of A. nodosum and F. vesiculosus) in 23 participants; no significant effect on glucose response was observed.
A randomized double-blind crossover trial administered either 500 mg or 1000 mg of Ascophyllum nodosum extract with white bread in 16 healthy subjects; neither dose produced significant effects on glucose or insulin versus control.
A 12-week randomized, placebo-controlled, parallel clinical trial used 500 mg/d of brown seaweed extract (A. nodosum and F. vesiculosus) in 56 overweight/obese prediabetic subjects.
A real-world observational study assessed 180 days of administration of a nutraceutical (Gdue) containing A. nodosum, F. vesiculosus, and chromium picolinate on metabolic syndrome components.
A pilot study in women with iodine insufficiency used 500 mg/d of Ascophyllum nodosum capsules for 14 days, resulting in nearly tripling of urinary iodine excretion and a 36% increase in TSH.
The British Herbal Pharmacopoeia described traditional preparations of F. vesiculosus as dried thallus at 5–10 g or liquid extract in 25% ethanol at 4–8 ml.
Soft extracts prepared with ethanol (45%) were traditionally used at 200–600 mg.
Clinical trial data are limited to inform on potential therapeutic applications for F. vesiculosus specifically, and clinical trials of bladderwrack are lacking to inform dosing recommendations.

8. Safety Considerations and Interactions

8.1 Iodine Toxicity and Thyroid Disruption

Rockweed can contain high concentrations of iodine; taking large amounts of iodine can cause or worsen some thyroid problems. Based on the known effects of iodine toxicity and case reports, the high iodine content in bladderwrack may lead to abnormal thyroid conditions; in theory, bladderwrack may increase or decrease blood thyroid hormone levels. In addition, acne-type skin lesions may occur and there are reports of severe acne exacerbation associated with high iodine intake from rockweed products.

8.2 Heavy Metal Contamination

Rockweed products may also contain heavy metals, which can cause heavy metal poisoning. Most adverse effects appear related to the high iodine content, heavy metal, or other contamination of bladderwrack preparations rather than to the seaweed itself; because of the potential contamination with heavy metals, its consumption should always be considered potentially unsafe unless sourced and tested rigorously. The presence of heavy metal contaminants in bladderwrack preparations, including arsenic, cadmium, chromium, or lead, may increase the risk of kidney toxicity if taken with drugs that cause kidney damage.

8.3 Drug Interactions

The EMA Community Herbal Monograph specifies that other herbal preparations containing Fucus vesiculosus, preparations containing iodine, or medicines for the thyroid gland should not be taken concomitantly.

Thyroid medications: In theory, the high iodine content of bladderwrack may interfere with drugs that act on the thyroid such as levothyroxine; use of bladderwrack and amiodarone may alter thyroid function due to high iodine levels in both agents; and use of iodine-containing agents such as bladderwrack with lithium may alter thyroid function.
Case report with lithium: One case report of hyperthyroidism was published in a patient diagnosed with bipolar disorder and under treatment with lithium who was also taking Fucus vesiculosus.
Antidiabetic medications: Extracts of bladderwrack may cause lowered blood sugar; caution is advised when using medications that may also lower blood sugar.
Anticoagulants and antiplatelet agents: Bladderwrack may increase the risk of bleeding when taken with herbs and supplements that are believed to increase the risk of bleeding. Fucus vesiculosus might slow blood clotting.
Hormonal drugs: Other endocrine hormones, estrogen levels, and progesterone levels may be affected, and therefore bladderwrack may interact with hormonal drugs. In a small study of premenopausal women with abnormal menstrual cycling histories (N=3), F. vesiculosus consumption increased menstrual cycle length and altered serum and urinary estrogen levels.

8.4 Pregnancy and Lactation

Safety during pregnancy and lactation has not been established; in the absence of sufficient data, the use during pregnancy and lactation is not recommended, per the EMA Community Herbal Monograph. Although iodine is a normal component of human milk, no data exist on the excretion of any organic components of seaweed into breastmilk; iodine and heavy metals, which are also present in bladderwrack, are excreted into milk; the recommendation is not to use seaweed during breastfeeding because of its high iodine content and potential contamination with heavy metals.

8.5 Gastrointestinal Adverse Effects

Gastrointestinal effects may occur with oral ingestion of bladderwrack/rockweed preparations. In one clinical study context, adverse events observed included abdominal pain, diarrhoea, and hypersensitivity, which resolved after discontinuation of the treatment.

8.6 Overall Safety Assessment

Fucus vesiculosus is possibly safe when applied to the skin, but possibly unsafe when taken by mouth; it may contain high concentrations of iodine. Clinical trial data are limited to inform on potential therapeutic applications for F. vesiculosus specifically, with most evidence extrapolated from studies reporting on brown seaweeds generally. Source geography and harvest conditions materially affect both heavy metal burden and iodine content; significant lot-to-lot variation is documented in the literature.

References

Health Conditions

Health conditions that Rockweed may help support.

No conditions available.

Body Systems

Body systems that Rockweed may help support.

No body systems available.